Harvard Bioscience, Inc. will announce its quarterly results for third quarter ended September 30, 2019 after market close on November 5, 2019 and hold a conference call to discuss the results for the third quarter on November 5, 2019 at 4:30 p.m.
HOLLISTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third quarter ended September 30, 2019 after market close on November 5, 2019 and hold a conference call to discuss the results for the third quarter on November 5, 2019 at 4:30 p.m. Eastern Time.
You can access the live conference call by dialing the following phone numbers: toll-free 1 (800) 708-4539 or international 1 (847) 619-6396 and referencing the conference ID# 49098277.
The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, log on to http://investor.harvardbioscience.com/ and click on the Earnings Call icon. The webcast will be available on the website through November 12, 2019.
Financial information presented on the call, including the earnings release, will be available on the investor relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of solutions to advance life science. Our products are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific Inc., VWR, and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada and China.
For more information, please visit our website at www.harvardbioscience.com.
CONTACT:
Michael Rossi
Chief Financial Officer
Tel: 508 893 8999
